| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| thioredoxin reductase | 9 | 0 | 0 | 9 |
| USP1 protein, partial | 9 | 0 | 0 | 9 |
| TDP1 protein | 17 | 0 | 0 | 17 |
| vitamin D3 receptor isoform VDRA | 8 | 0 | 0 | 8 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| flap endonuclease 1 | 4 | 0 | 0 | 4 |
| serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
| DNA polymerase iota isoform a (long) | 5 | 0 | 0 | 5 |
| urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
| plasminogen precursor | 4 | 0 | 0 | 4 |
| urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
| geminin | 17 | 0 | 0 | 17 |
| DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
| fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
| Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Transthyretin | 0 | 1 | 1 | 4 |
| Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
| Fatty acid-binding protein, adipocyte | 0 | 1 | 1 | 2 |
| Cyclin-A2 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 1 | 2 |
| Cyclin-dependent kinase 2 | 0 | 1 | 1 | 2 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
| Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
| Carbonic anhydrase 1 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 2 |
| Alanine racemase, biosynthetic | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 6 | 0 | 0 | 6 |
| Luciferase | 5 | 0 | 0 | 5 |
| glp-1 receptor, partial | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 8 | 0 | 0 | 8 |
| RAR-related orphan receptor gamma | 14 | 0 | 0 | 14 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| Fumarate hydratase | 6 | 0 | 0 | 6 |
| GLI family zinc finger 3 | 13 | 0 | 0 | 13 |
| AR protein | 20 | 0 | 0 | 20 |
| caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 1, group I, member 3 | 16 | 0 | 0 | 16 |
| progesterone receptor | 12 | 0 | 0 | 12 |
| glucocorticoid receptor [Homo sapiens] | 17 | 0 | 0 | 17 |
| retinoic acid nuclear receptor alpha variant 1 | 14 | 0 | 0 | 14 |
| retinoid X nuclear receptor alpha | 14 | 0 | 0 | 14 |
| estrogen-related nuclear receptor alpha | 17 | 0 | 0 | 17 |
| farnesoid X nuclear receptor | 12 | 0 | 0 | 12 |
| pregnane X nuclear receptor | 19 | 0 | 0 | 19 |
| estrogen nuclear receptor alpha | 22 | 0 | 0 | 22 |
| polyprotein | 6 | 0 | 0 | 6 |
| 67.9K protein | 5 | 0 | 0 | 5 |
| peroxisome proliferator activated receptor gamma | 10 | 0 | 0 | 10 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 12 | 0 | 0 | 12 |
| caspase-3 | 4 | 0 | 0 | 4 |
| IDH1 | 4 | 0 | 0 | 4 |
| euchromatic histone-lysine N-methyltransferase 2 | 10 | 0 | 0 | 10 |
| aryl hydrocarbon receptor | 13 | 0 | 0 | 13 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 12 | 0 | 0 | 12 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 12 | 0 | 0 | 12 |
| nuclear receptor subfamily 1, group I, member 2 | 6 | 0 | 0 | 6 |
| Histone H2A.x | 7 | 0 | 0 | 7 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
| transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 13 | 0 | 0 | 13 |
| histone deacetylase 9 isoform 3 | 5 | 0 | 0 | 5 |
| heat shock protein beta-1 | 8 | 0 | 0 | 8 |
| mitogen-activated protein kinase 1 | 9 | 0 | 0 | 9 |
| Vif | 0 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 12 | 0 | 0 | 12 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 10 | 0 | 0 | 10 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| ATP-binding cassette sub-family C member 3 | 0 | 7 | 0 | 7 |
| Multidrug resistance-associated protein 4 | 0 | 7 | 0 | 7 |
| Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
| Bile salt export pump | 0 | 11 | 0 | 11 |
| Interferon beta | 9 | 0 | 0 | 9 |
| Cellular tumor antigen p53 | 17 | 0 | 0 | 17 |
| Integrin beta-3 | 3 | 0 | 0 | 3 |
| Integrin alpha-IIb | 3 | 0 | 0 | 3 |
| Methionine aminopeptidase | 0 | 3 | 0 | 3 |
| Glutamate receptor 2 | 9 | 0 | 0 | 9 |
| Fatty-acid amide hydrolase 1 | 0 | 3 | 0 | 3 |
| Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
| Canalicular multispecific organic anion transporter 1 | 0 | 7 | 0 | 7 |
| ATPase family AAA domain-containing protein 5 | 9 | 0 | 0 | 9 |
| Ataxin-2 | 9 | 0 | 0 | 9 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 0 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 2 |
| Procathepsin L | 0 | 2 | 0 | 2 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 0 | 0 | 1 |
| Cysteine protease | 0 | 1 | 0 | 1 |
| Mitochondrial 2-oxodicarboxylate carrier | 0 | 1 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 4 | 1 | 8 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 6 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 4 | 0 | 0 | 5 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
| Chain A, GTPase KRas, isoform 2B | 0 | 0 | 1 | 1 |
| Chain A, GTPase KRas, isoform 2B | 0 | 0 | 1 | 1 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 2 |
| GTPase KRas | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 4 | 1 | 5 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 12 | 0 | 0 | 12 |
| thyroid hormone receptor beta isoform a | 9 | 0 | 0 | 9 |
| galanin receptor type 3 | 0 | 1 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 18 | 0 | 0 | 18 |
| Glucocorticoid receptor | 0 | 4 | 1 | 10 |
| Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
| Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
| ORF73 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
| Chain A, Ferritin light chain | 5 | 0 | 0 | 5 |
| acetylcholinesterase | 5 | 0 | 0 | 5 |
| SMAD family member 2 | 6 | 0 | 0 | 6 |
| SMAD family member 3 | 6 | 0 | 0 | 6 |
| Microtubule-associated protein tau | 9 | 0 | 0 | 9 |
| estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
| peroxisome proliferator-activated receptor delta | 8 | 0 | 0 | 8 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| activating transcription factor 6 | 6 | 0 | 0 | 6 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| Caspase-2 | 0 | 0 | 1 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 8 | 0 | 0 | 8 |
| hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
| perilipin-5 | 0 | 1 | 0 | 1 |
| perilipin-1 | 0 | 1 | 0 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 4 | 0 | 4 |
| 3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
| ATP-citrate synthase | 0 | 0 | 0 | 1 |
| Ribonuclease T | 0 | 0 | 0 | 1 |
| Cell death-related nuclease 4 | 0 | 0 | 0 | 1 |
| 3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| Chain A, Cruzipain | 4 | 0 | 0 | 4 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| Spike glycoprotein | 4 | 1 | 0 | 5 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 3 | 3 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| PPM1D protein | 4 | 0 | 0 | 4 |
| Smad3 | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 7 | 0 | 0 | 7 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
| GALC protein | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| G | 4 | 0 | 0 | 4 |
| cytochrome P450 2D6 | 6 | 0 | 0 | 6 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| huntingtin isoform 2 | 3 | 0 | 0 | 3 |
| cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 5 | 0 | 1 | 6 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 0 | 1 | 6 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 5 | 0 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 0 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 0 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 0 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 0 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 0 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 0 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 0 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 0 | 1 | 6 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 0 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 0 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 0 | 1 | 6 |
| GABA theta subunit | 5 | 0 | 1 | 6 |
| Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | 5 | 0 | 1 | 6 |
| cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
| Estrogen receptor beta | 0 | 1 | 0 | 1 |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 26A1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Camphor 5-monooxygenase | 0 | 0 | 0 | 1 |
| Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Epoxide hydrolase 1 | 0 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 2 | 0 | 3 |
| Steroid 21-hydroxylase | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 2 | 0 | 2 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| Gonadotropin-releasing hormone receptor | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 4F2 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| dopamine D1 receptor | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Alkaline phosphatase, placental type | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| Tyrosine-protein kinase ABL1 | 0 | 3 | 0 | 3 |
| Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| Calmodulin-domain protein kinase 1 | 0 | 1 | 0 | 1 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| TSHR protein | 1 | 0 | 0 | 1 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| Parkin | 1 | 0 | 0 | 1 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
| Aurora kinase A | 0 | 1 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 1 | 0 | 1 |
| 3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase JAK2 | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 1 | 0 | 0 | 1 |
| Platelet-derived growth factor receptor beta | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Mast/stem cell growth factor receptor Kit | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 1 | 1 | 0 | 2 |
| Signal transducer and activator of transcription 3 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 8 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Angiopoietin-1 receptor | 0 | 1 | 0 | 1 |
| Anoctamin-1 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 0 | 1 |
| GLS protein | 2 | 0 | 0 | 2 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| WRN | 1 | 0 | 0 | 1 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| Valosin-containing protein | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Succinyl-diaminopimelate desuccinylase | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| galactokinase | 1 | 0 | 0 | 1 |
| Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
| Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
| Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Chain H, Immunoglobulin Igg1 Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Immunoglobulin Igg1 Lambda Light Chain | 0 | 0 | 1 | 1 |
| Chain A, DODECIN | 0 | 0 | 1 | 1 |
| Chain A, DODECIN | 0 | 0 | 1 | 1 |
| Chain C, DODECIN | 0 | 0 | 1 | 1 |
| Chain E, DODECIN | 0 | 0 | 1 | 1 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
| Riboflavin-binding protein | 0 | 1 | 1 | 2 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 3 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| Thyroid hormone receptor alpha | 0 | 2 | 3 | 5 |
| Thyroid hormone receptor beta | 0 | 2 | 3 | 5 |
| Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 4 | 4 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |